Social media

Recognising ICON’s Environmental, Social & Governance (ESG) commitment through our ICON Cares programme, we are honoured to be named one of the world’s best by TIME/ Statista. This list ranks the world’s 500 most sustain...

Recognising ICON’s Environmental, Social & Governance (ESG) commitment through our ICON Cares programme, we are honoured to be named one of the world’s best by TIME/ Statista. This list ranks the world’s 500 most susta...

Today marks the final day of #OCTDACH, and our ICON team of experts is ready to welcome you at booth \#8. This is your chance to connect with leaders in clinical research and digital health who are driving innovation ac...

Nearly 30 million adults in the U.S. live with obstructive sleep apnea (OSA) – a chronic condition requiring ongoing monitoring. Until now, clinicians lacked a validated patient-reported tool for tracking treatment respo...

From imaging to cardiovascular care, AI-enabled devices are everywhere. But how do you navigate FDA regulations when there’s no unique pathway? Explore key insights on 510(k), De Novo, and lifecycle management in our new...

From imaging to cardiovascular care, AI-enabled devices are everywhere. But how do you navigate FDA regulations when there’s no unique pathway? Explore key insights on 510(k), De Novo, and lifecycle management in our new...

World Diabetes Day takes place on 14 November 2025. As the incidence of obesity and diabetes have grown in tandem to epidemic proportions, there is growing demand for treatments intended for patients with both conditions...

World Diabetes Day takes place on 14 November. Read the article to find out how multi-indication drug development has gained traction due to a better understanding of glucose metabolism and its critical link to various d...

Did you know? JCA findings aren’t binding—but they do shape national HTA decisions. Learn how to tailor your strategy for each EU market while staying aligned with JCA requirements. Download the whitepaper: https://ow.ly...

Did you know? JCA findings aren’t binding—but they do shape national HTA decisions. Learn how to tailor your strategy for each EU market while staying aligned with JCA requirements. Download the whitepaper: https://ow.ly...

Digital health technologies don’t just modernize clinical trials; they deliver measurable business value. From reducing trial timelines to improving patient retention and cutting costs, DHTs are proving their ROI across...

For sponsors committed to leveraging digital measures in their protocol designs: How do you select the right digital measure? For those searching for a solution. ICON’s proprietary Atlas Network supports sponsors in sel...